Yi Wen et al., 2011-03-18: The paper that states the alternative-electron-carrier mechanism explicitly: methylene blue takes electrons from NADH and hands them to cytochrome c, bypassing complexes I/III, with protection in cell and animal models of Parkinsonism and stroke.
we demonstrated that methylene blue (MB) functions as an alternative electron carrier, which accepts electrons from NADH and transfers them to cytochrome c and bypasses complex I/III blockage.
Abstract
Yi Wen et al., 2011-03-18: The paper that states the alternative-electron-carrier mechanism explicitly: methylene blue takes electrons from NADH and hands them to cytochrome c, bypassing complexes I/III, with protection in cell and animal models of Parkinsonism and stroke. Mixed model study: cultured neuronal cells plus two animal models (rotenone Parkinson model and transient focal cerebral ischemia in mice). Country: United States. Dose: 'low nanomolar concentrations' in vitro; in vivo dosing per the paper (not in the abstract). Route: in vitro incubation; in vivo route stated in full text. Funder: US NIH (NINDS NS048254, NS054687, NS054651; NIA P01 AG010485, P01 AG022550, R01 AG023695; NIEHS ES015317) and non-US-government support. Conflicts: none declared in the record. Comparator: vehicle/no-MB controls; a de novo synthesised MB derivative with the redox centre disabled by N-acetylation served as a mechanistic negative control. Note: the paper's own control is important – the redox-disabled analogue had no effect on complex activities, which is the strongest form of the claim that the redox chemistry is the mechanism. Also filed as MTE-05, MTE-49 (claims C1, C2, F2). Study type: animal.
